Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing for combination products in both the Pharma and med device industries. This two-day summit features expert insight into combination product development, and the complex quality, safety, and regulatory compliance issues facing the CP market. Pharma Ed’s Combination Products Summit 2026 provides comprehensive coverage of current and future trends in combination product development for drugs, biologics and medical devices.

View the event here.